Polymorphism in the hMSH2 gene (gISV12-6T > C) is a prognostic factor in non-small cell lung cancer

Han Shui Hsu, I. Hsuan Lee, Wen Hu Hsu, Wei Ting Kao, Yi Ching Wang

研究成果: Article同行評審

18 引文 斯高帕斯(Scopus)

摘要

Genetic polymorphisms at the genes involved in mismatch repair may determine individual's susceptibility to cancer initiation and progression. However, the prognostic significance of hMSH2 gIVS12-6T > C polymorphism (T-C substitution at the -6 intronic splice acceptor site of exon 13) in non-small cell lung cancer (NSCLC) remains unclear. Therefore, we investigated the frequency of hMSH2 gIVS12-6T > C polymorphism in 156 NSCLC patients and 235 cancer-free individuals matched for age, gender and smoking habit. The correlations between hMSH2 genotypes and protein expression and survival of the patients were also analyzed. The frequencies of hMSH2 genotypes T/T, T/C, and C/C were 37.4%, 43.0%, and 19.6%, respectively, and the variant (C) allele was represented at a significantly higher frequency in the general Taiwanese population than in non-Asian populations (P < 0.0001, χ2 test). No significant difference in hMSH2 genotype distribution was found between NSCLC patients and cancer-free controls (P = 0.255, multivariate logistic regression). However, the homozygous wild-type T/T genotype was significantly associated with a poor prognosis (P = 0.007, log-rank test). Our study showed that the frequency of the variant C allele was significantly higher in the general Taiwanese population than in non-Asian populations and the T/T genotype of hMSH2 gIVS12-6T > C polymorphism was a poor prognostic factor in NSCLC patients.

原文English
頁(從 - 到)123-130
頁數8
期刊Lung Cancer
58
發行號1
DOIs
出版狀態Published - 2007 十月

All Science Journal Classification (ASJC) codes

  • 腫瘤科
  • 肺和呼吸系統醫學
  • 癌症研究

指紋

深入研究「Polymorphism in the hMSH2 gene (gISV12-6T > C) is a prognostic factor in non-small cell lung cancer」主題。共同形成了獨特的指紋。

引用此